ReproCELL Incorporated Logo

ReproCELL Incorporated

Provider of stem cell technology and services for research and regenerative medicine.

4978 | T

Overview

Corporate Details

ISIN(s):
JP3974770004
LEI:
Country:
Japan
Address:
横浜市港北区新横浜3−8−11

Description

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-13 07:35
確認書
Japanese ZIP 8.1 KB
2025-11-13 07:35
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese ZIP 219.0 KB
2025-06-26 02:41
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 23.4 KB
2025-06-26 02:41
確認書
Japanese ZIP 8.1 KB
2025-06-26 02:40
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 1.1 MB
2024-11-13 07:31
確認書
Japanese ZIP 8.1 KB
2024-11-13 07:31
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 221.1 KB
2024-06-26 03:02
臨時報告書
Japanese ZIP 28.0 KB
2024-06-25 07:31
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 22.2 KB
2024-06-25 07:30
確認書
Japanese ZIP 8.2 KB
2024-06-25 07:29
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 1.2 MB
2024-05-23 08:02
臨時報告書
Japanese ZIP 20.0 KB
2024-02-09 07:24
確認書
Japanese ZIP 8.2 KB
2024-02-09 07:23
四半期報告書-第22期第3四半期(2023/10/01-2023/12/31)
Japanese ZIP 227.6 KB
2023-11-10 07:05
四半期報告書-第22期第2四半期(2023/07/01-2023/09/30)
Japanese ZIP 213.2 KB

Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ReproCELL Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Evogene Ltd. Logo
A computational biology company using AI to develop life-science products.
Israel
EVGN
Evotec SE Logo
A life science company offering drug discovery and development partnership solutions.
Germany
EVT
EXICURE, INC. Logo
Early-stage biotech developing nucleic acid therapies based on SNA technology.
United States of America
XCUR
EyeGene,Inc Logo
Develops gene/cell therapies for age-related diseases and preventive vaccines.
South Korea
185490
Femtobiomed Inc. Logo
Develops a non-viral intracellular delivery platform for cell and gene therapy.
South Korea
327610
Develops AI data center campuses with co-located hybrid power generation.
United States of America
FRMI
Fluicell AB Logo
A biotech firm creating engineered tissues for regenerative medicine and drug development.
Sweden
FLUI
Foghorn Therapeutics Inc. Logo
Develops medicines targeting the chromatin regulatory system for oncology.
United States of America
FHTX
Fortrea Holdings Inc. Logo
A global CRO providing clinical development and patient access solutions to life sciences.
United States of America
FTRE
FUSION ANTIBODIES PLC Logo
CRO providing end-to-end services for preclinical antibody development.
United Kingdom
FAB

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.